2011 - IPITA - Prague


This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Poster

1.188 - The importance of animal research in the history of Langerhans Islet transplantation.

Presenter: E. , Číhalová 1, ,
Authors: E. Číhalová

P-188

The importance of animal research in the history of Langerhans Islet transplantation.

E. ?íhalová1
Institute Clinical and Experimental Medicine, Langerhans Islet Laboratory, Prague, Czech Republic

The role of animal experimentation has been vital in the research and later practical application in therapeutic use. The history of Langerhans Islets transplantation began in 1869, with Paul Langerhans discovering islets in animal models but their function remained unknown. E.L. Opie, in 1901, also using animal models explained the islets function and in 1902 L.W. Ssobolew demonstrated that islets were responsible for sugar distribution. Later in 1904, Jean De Meyer named the products of islets as “insulin”. The breakthrough in islet research came in 1965 with S. Moslkalewksi employing rats for the isolation and culture of islets. The next significant step was in 1967 by P.E. Lacy and M. Kostianowsky who isolated intact islets from the rat pancreas. In 1971, C. Ricordi and his team started research about the method of islet transplantation from various animals. The next year, P.E. Lacy surgically transplanted islets between animals. In 1988, Ricordi developed the pioneering method for mechanical isolation of large amounts of islets very easily firstly from pigs and later from humans. The most recent development in 2000 in Edmonton, Canada, was when a research team reported seven Type 1 diabetic patients released from daily insulin injections after islet transplantation. Initial phases of this research performed on animals allow for translation of ideas to clinical practice.

/

P-188

The importance of animal research in the history of Langerhans Islet transplantation.

E. ?íhalová1
Institute Clinical and Experimental Medicine, Langerhans Islet Laboratory, Prague, Czech Republic

The role of animal experimentation has been vital in the research and later practical application in therapeutic use. The history of Langerhans Islets transplantation began in 1869, with Paul Langerhans discovering islets in animal models but their function remained unknown. E.L. Opie, in 1901, also using animal models explained the islets function and in 1902 L.W. Ssobolew demonstrated that islets were responsible for sugar distribution. Later in 1904, Jean De Meyer named the products of islets as “insulin”. The breakthrough in islet research came in 1965 with S. Moslkalewksi employing rats for the isolation and culture of islets. The next significant step was in 1967 by P.E. Lacy and M. Kostianowsky who isolated intact islets from the rat pancreas. In 1971, C. Ricordi and his team started research about the method of islet transplantation from various animals. The next year, P.E. Lacy surgically transplanted islets between animals. In 1988, Ricordi developed the pioneering method for mechanical isolation of large amounts of islets very easily firstly from pigs and later from humans. The most recent development in 2000 in Edmonton, Canada, was when a research team reported seven Type 1 diabetic patients released from daily insulin injections after islet transplantation. Initial phases of this research performed on animals allow for translation of ideas to clinical practice.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada